Drug Search Results
More Filters [+]

Etodolac

Alternative Names: etodolac, lodine xl, lodine, nudroxipak e-400
Latest Update: 2024-08-19
Latest Update Note: News Article

Product Description

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain, and helps to relieve symptoms of arthritis (eg, osteoarthritis and rheumatoid arthritis), including inflammation, swelling, stiffness, and joint pain. However, this medicine does not cure arthritis and will help you only as long as you continue to take it. (Sourced from: https://www.mayoclinic.org/drugs-supplements/etodolac-oral-route/description/drg-20069756)

Mechanisms of Action: COX2 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Bangladesh | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Denmark | Dominican Republic | Egypt | France | Germany | Hong Kong | India | Indonesia | Ireland | Israel | Italy | Korea | Lebanon | Lithuania | Malta | New Zealand | Pakistan | Peru | Philippines | Portugal | Russia | Serbia | Slovenia | South Africa | Switzerland | Taiwan | Thailand | Turkey | Ukraine | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Etodolac

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events